10.1111/bph.12461 Br
In addition, first oral GLP-1 receptor agonist (oral semaglutide) was recently approved ( Table 1
Inhibits beta cell apoptosis
Metformin Metformin , sometimes referred to by its previous brand name, Glucophage, is FDA-approved as a diabetes medication and shares some side effects with Ozempic
Lixisenatide: Gastrointestinal: acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction Hepatobiliary: cholecystitis, cholelithiasis requiring cholecystectomy Neurologic: dysgeusia, dysesthesia Pulmonary: pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation
### The Real First-Year Cost | Phase | Duration | Cost Range | |-------|----------|-----------| | Titration (1-4mg) | Months 1-3 | $500-900 | | Therapeutic (4-8mg) | Months 4-12 | $2,400-4,500 | | **Year 1 Total** | 12 months | **$2,900-5,400** | That works out to roughly $8-15 per day